Nano Science and Technology InstituteNano Science and Technology Institute
Nano Science and Technology Institute 2005 NSTI Nanotechnology Conference & Trade Show
Nanotech 2005
Bio Nano 2005
Business & Investment
Nano Impact Workshop
Program
Sessions
Sunday
Monday
Tuesday
Wednesday
Thursday
Index of Authors
Index of Keywords
Keynote Presentations
Confirmed Speakers
Participating Companies
Industry Focus Sessions
Nanotech Expo
Special Symposia
Conferences
Sponsors
Exhibitors
Venue 2005
Organization
Press Room
Subscribe
Site Map
 
Nanotech 2005 At A Glance
Nanotech Proceedings
Nanotechnology Proceedings
Global Partner
nano tech
Supporting Organizations
Nanotech 2005 Supporting Organization
Media Sponsors
Nanotech 2005 Medias Sponsors
Event Contact
696 San Ramon Valley Blvd., Ste. 423
Danville, CA 94526
Ph: (925) 353-5004
Fx: (925) 886-8461
E-mail:
 
 

Addressing Challenges in Cancer Diagnosis and Therapy in the 12st Century

Thomas J. Kipps

Professor of Medicine; Head, Division of Hematology/Oncology, Associate Director, UCSD Gene Therapy Program; Director in Immunology, UCSD Cancer Center, US

Dr. Kipps is Head, Division of Hematology/Oncology, Associate Director, UCSD Gene Therapy Program; Director in Immunology, UCSD Cancer Center. Dr. Kipps research focuses on 4 areas: 1) Human B cell physiology with emphasis on B cell antigen presentation, accessory molecules involved in cognate T-cell <-> B-cell interactions, signal transduction, and immunoglobulin gene expression, 2) Human B cell lymphoproliferative diseases with emphasis on pathogenic mechanisms, immunoglobulin gene expression, and innovative forms of immunotherapy, 3) In vitro or in vivo somatic cell transfection or transduction using plasmid DNA or viral expression vectors for gene immunotherapy of neoplastic disease, and 4) structure-function studies of immunoglobulin or accessory molecules involved in signal transduction or cognate cell-cell interactions. Dr. Kipps is deputy director of the UCSD Comprehensive Cancer Center, and also directs the CLL Research Consortium, a multi-institution research program sponsored by the National Cancer Institute to study chronic lymphocytic leukemia (CLL). The consortium brings together the nation’s top scientists from different disciplines—genetics, cell biology, biochemistry, immunology and pharmacology—to conduct an integrated program of basic and clinical research focused on CLL.

 
Gold Sponsors
Nanotech Gold Sponsors
Silver Sponsors
Nanotech Silver Sponsors
Gold Key Sponsors
Nanotech Gold Key Sponsors
Nanotech Ventures Sponsors
Nanotech Ventures Sponsors
Sponsors
Nanotech Sponsors
News Headlines
NSTI Online Community
 
 

© Nano Science and Technology Institute, all rights reserved.
Terms of use | Privacy policy | Contact